The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide ... Ozempic for diabetes and obesity therapy Wegovy ...

WEIGHT loss jabs could banish blues as well as bellies, a study claims. People taking the injections showed “significantly ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Generic versions of Ozempic, Wegovy, and Mounjaro flooded into the market via med spas and online pharmacies. In February of this year, the FDA announced that the shortage had been resolved—and ...

The study published in the journal JAMA Ophthalmology focused on semaglutide, the GLP-1 agonist in Novo Nordisk’s diabetes therapy Ozempic ... of suicide, but no strong evidence for a link ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

A grandma of 11 and a New Jersey man have joined the growing chorus of users of the wildly popular weight loss drugs Ozempic and Wegovy who say ... where she could no longer see a computer screen.

The pharmaceutical company that makes the weight-loss drug Wegovy and the diabetes medication Ozempic secured a court ... names Mounjaro and Zepbound, was no longer in short supply.

Semaglutide, the active ingredient in Ozempic and Wegovy, mimics a natural hormone called GLP-1, according to WebMD. It works by helping regulate blood sugar, slowing down stomach emptying and ...